Recent advances in understanding of genetic susceptibility to breast cancer (Q41170356)

27 September 2017

1 reference

title

Recent advances in understanding of genetic susceptibility to breast cancer (English)

1 reference

27 September 2017

Stratton MR

1

1 reference

27 September 2017

1 January 1996

1 reference

27 September 2017

Human Molecular Genetics

1 reference

27 September 2017

5 Spec No

1 reference

27 September 2017

1515-1519

1 reference

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

27 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

Jewish religion and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

Growth retardation and tumour inhibition by BRCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

Isolation of the mouse homologue of BRCA1 and genetic mapping to mouse chromosome 11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

Aberrant subcellular localization of BRCA1 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

BRCA1 is secreted and exhibits properties of a granin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

BRCA1 mutations in primary breast and ovarian carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

A somatic BRCA1 mutation in an ovarian tumour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

Identification of the breast cancer susceptibility gene BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

Open access to sequence data 'will boost hunt for breast cancer gene'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

Internal repeats in the BRCA2 protein sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

BRCA2 mutations in primary breast and ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

Mutation analysis in the BRCA2 gene in primary breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

Low incidence of BRCA2 mutations in breast carcinoma and other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

BRCA1Mutations in a Population-Based Sample of Young Women with Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

Localization of the gene for Cowden disease to chromosome 10q22–23

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F5.SUPPLEMENT_1.1515

10.1093/HMG/5.SUPPLEMENT_1.1515

21 January 2018

Identifiers

DOI

1 reference

27 September 2017

1 reference

PubMed ID

8875258